Drug Type Prophylactic vaccine |
Synonyms RSV-hMPV-PIV |
Target- |
Mechanism- |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metapneumovirus infection | Preclinical | CN | 24 May 2024 | |
Parainfluenzae virus infection | Preclinical | CN | 24 May 2024 | |
Pneumonia due to respiratory syncytial virus | Preclinical | CN | 24 May 2024 |